Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies.
Akhtar OS, Szabo A, Bhatlapenumarthi V, Forsberg M, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Patel T, Shrestha A, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, Shah MR, Bag A, D'Souza A, Schinke C, Chakraborty R, Shah N, Mohan M.
Akhtar OS, et al. Among authors: bhutani d.
Br J Haematol. 2024 Nov;205(5):1830-1834. doi: 10.1111/bjh.19700. Epub 2024 Aug 27.
Br J Haematol. 2024.
PMID: 39192546